Montelukast Sodium Tablet
Product Images NDC 68788-8610

6 FDA label images from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 68788-8610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart (Figure 1)

Chart (Figure 1)
A line graph showing change in height (cm) over weeks on treatment for three groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and placebo. The x-axis represents weeks on treatment from -19 to 56, and the y-axis represents change in height ranging from -3 to 7 cm. Montelukast shows a slightly greater increase in height compared to Beclomethasone and placebo over the observed period.*
FDA Label Image

Str (Structure)

Str (Structure)
Chemical structure diagram of Montelukast Sodium, a human prescription drug. The structure shows multiple aromatic rings, a sulfur atom, a cyclopropyl group connected to a sodium carboxylate moiety, and several substituents including a chlorine atom and isopropyl groups.*
FDA Label Image

Chart2 (Figure 2)

Chart2 (Figure 2)
A line graph depicting mean percent change from baseline over 15 weeks in treatment for Montelukast Sodium versus placebo groups. The x-axis shows weeks in treatment, including a washout period at week 15, and the y-axis represents mean percent change. Montelukast Sodium shows higher improvement than placebo throughout the treatment period.*
FDA Label Image
FDA Label Image
FDA Label Image

Montelukast Sodium Tablets 10mg (10mg Dahej)

Montelukast Sodium Tablets 10mg (10mg Dahej)
Montelukast Sodium Tablets 10 mg label from Preferred Pharmaceuticals Inc. The label indicates the product is generic for Singulair, with each tablet containing 10.4 mg Montelukast Sodium USP equivalent to 10 mg Montelukast. It includes storage instructions, manufacturer information (Torrent Pharmaceuticals Limited), and a barcode. The label also displays bilingual dosing instructions in English and Spanish on a yellow background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.